share_log

INNOVATION PHARMACEUTICALS INC | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions

INNOVATION PHARMACEUTICALS INC | SC 13G:超过5%持股股东披露文件

美股SEC公告 ·  2021/02/12 05:46
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息